Mc Clarren Financial Advisors, Inc. Abb Vie Inc. Transaction History
Mc Clarren Financial Advisors, Inc.
- $795 Million
- Q3 2024
A detailed history of Mc Clarren Financial Advisors, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Mc Clarren Financial Advisors, Inc. holds 707 shares of ABBV stock, worth $119,928. This represents 0.01% of its overall portfolio holdings.
Number of Shares
707
Previous 343
106.12%
Holding current value
$119,928
Previous $114,000
37.72%
% of portfolio
0.01%
Previous 0.08%
Shares
11 transactions
Others Institutions Holding ABBV
# of Institutions
3,837Shares Held
1.25BCall Options Held
15.7MPut Options Held
11.3M-
Vanguard Group Inc Valley Forge, PA172MShares$29.1 Billion0.62% of portfolio
-
Black Rock Inc. New York, NY136MShares$23.1 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.1MShares$13.4 Billion0.65% of portfolio
-
Jpmorgan Chase & CO New York, NY52.1MShares$8.84 Billion0.84% of portfolio
-
Morgan Stanley New York, NY38.7MShares$6.57 Billion0.56% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $300B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...